Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 5/20 | 0.52 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.51 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.51 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.40 |
| ▸ | RRM1 | P23921 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30445693 | 1.00 | TERT (0.52) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL30306242 | 1.00 | TERT (0.52) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL10789429 | 1.00 | TERT (0.52) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL30379876 | 1.00 | TERT (0.52) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL14043915 | 0.95 | TERT (0.47) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL29531486 | 0.93 | GNAI3 (0.57) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL345265 | 0.93 | GNAI3 (0.57) | TERTGNAI3GNAO1GNAI1GSR | |
| SCHEMBL345264 | 0.93 | GNAI3 (0.57) | TERTGNAI3GNAO1GNAI1GSR | |
| Hydrochloric Acid SCHEMBL23608082 | 0.92 | GNAI3 (0.55) | TERTGNAI3GNAO1GNAI1GSR | |
| Hydrochloric Acid SCHEMBL8939074 | 0.92 | GNAI3 (0.55) | TERTGNAI3GNAO1GNAI1GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682173-A1 | METHOD FOR PRODUCING RADIOLABELED ANTIBODY, RADIOLABELED ANTIBODY, AND RADIOACTIVE MEDICINE | Kagoshima University (JP) | 2026-01-21 | — | — | EP | claimed |
| WO-2024190896-A1 | METHOD FOR PRODUCING RADIOLABELED ANTIBODY, RADIOLABELED ANTIBODY, AND RADIOACTIVE MEDICINE | 国立大学法人 鹿児島大学 | 2024-09-19 | — | — | WO | claimed |
| EP-4400509-A1 | COMPOUND, SALT OF COMPOUND, ANTIBODY MODIFICATION REAGENT, METHOD FOR PRODUCING MODIFIED ANTIBODY, AND MODIFIED ANTIBODY | Kagoshima University (JP) | 2024-07-17 | — | — | EP | claimed |
| WO-2023038082-A1 | COMPOUND, SALT OF COMPOUND, ANTIBODY MODIFICATION REAGENT, METHOD FOR PRODUCING MODIFIED ANTIBODY, AND MODIFIED ANTIBODY | 国立大学法人 鹿児島大学 | 2023-03-16 | — | — | WO | claimed |
| EP-0142231-B1 | PROCESS FOR PRODUCING SEQUENTIAL POLYAMINO ACID RESIN | NITTO BOSEKI CO., LTD. (JP) | 1987-11-11 | — | — | EP | claimed |
| EP-0142231-A1 | Process for producing sequential polyamino acid resin | NITTO BOSEKI CO., LTD. (JP) | 1985-05-22 | — | — | EP | claimed |
| EP-4682173-A1 | METHOD FOR PRODUCING RADIOLABELED ANTIBODY, RADIOLABELED ANTIBODY, AND RADIOACTIVE MEDICINE | Kagoshima University (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-4636087-A1 | ANTI-GPA33 ANTIBODY AND UTILIZATION THEREOF | Kagoshima University (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20240425584-A1 | MECHANICALLY INTERLOCKING COMPLEXES | CITY OF HOPE | 2024-12-26 | — | — | US | disclosed |
| WO-2024190896-A1 | METHOD FOR PRODUCING RADIOLABELED ANTIBODY, RADIOLABELED ANTIBODY, AND RADIOACTIVE MEDICINE | 国立大学法人 鹿児島大学 | 2024-09-19 | — | — | WO | disclosed |
| US-20240299561-A1 | HISTIDINE-SELECTIVE POLYMER REAGENTS | NEKTAR THERAPEUTICS | 2024-09-12 | — | — | US | disclosed |
| EP-4400509-A1 | COMPOUND, SALT OF COMPOUND, ANTIBODY MODIFICATION REAGENT, METHOD FOR PRODUCING MODIFIED ANTIBODY, AND MODIFIED ANTIBODY | Kagoshima University (JP) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024111576-A1 | ANTI-GPA33 ANTIBODY AND UTILIZATION THEREOF | 国立大学法人 鹿児島大学 | 2024-05-30 | — | — | WO | disclosed |
| US-11897952-B2 | Mechanically interlocking complexes | CITY OF HOPE | 2024-02-13 | — | — | US | disclosed |
| US-20230357763-A1 | Morpholinos with Increased Delivery Efficiency | MORPHOLINO THERAPEUTICS LLC | 2023-11-09 | — | — | US | disclosed |
| US-11718824-B2 | Synthetic attachment medium for cell culture | CORNING INCORPORATED (US) | 2023-08-08 | — | — | US | disclosed |
| WO-2023038082-A1 | COMPOUND, SALT OF COMPOUND, ANTIBODY MODIFICATION REAGENT, METHOD FOR PRODUCING MODIFIED ANTIBODY, AND MODIFIED ANTIBODY | 国立大学法人 鹿児島大学 | 2023-03-16 | — | — | WO | disclosed |
| WO-2022266498-A1 | HISTIDINE-SELECTIVE POLYMER REAGENTS | NEKTAR THERAPEUTICS (US) | 2022-12-22 | — | — | WO | disclosed |
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2022-08-30 | — | — | US | disclosed |
| CN-110591079-B | Preparation method of monofunctional nonlinear polyethylene glycol | 厦门赛诺邦格生物科技股份有限公司 | 2022-08-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, VIP, NPY1R | TERT 3898/4885GNAI3 3041/4885GNAO1 2023/4885 |
| US-11897952-B2 | Mechanically interlocking complexes | FCGR3B, FCGR2A, FCGRT | TERT 3771/4885GNAI3 3286/4885GNAO1 4112/4885 |
| US-20240299561-A1 | HISTIDINE-SELECTIVE POLYMER REAGENTS | HNMT, PHYKPL, PHPT1 | TERT 4516/4885GNAI3 3279/4885GNAO1 4093/4885 |
| US-20240425584-A1 | MECHANICALLY INTERLOCKING COMPLEXES | FCGR3B, FCGR2A, FCGRT | TERT 3771/4885GNAI3 3286/4885GNAO1 4112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.